DIRS.INFO The most relevant business & tech news

☆ Exclusive: Astarte Medical is shutting down. Here's why the infant tech startup decided to close its doors.
▼ + stars: | 2024-02-05 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +7 min

Tracy Warren cofounded Astarte Medical in 2016 to improve care for premature babies. Astarte, which sells software to standardize nutrition for babies in intensive care units, had raised $14 million in venture funding to date and landed contracts with four hospitals. Last year, the startup wasn't able to land as many new contracts as it hoped, with hospitals struggling to manage their slim margins. But Astarte ultimately decided not to make the promise to build AI into its tech for clinical decision-making. The startup is hoping to find a buyer by the end of the first quarter of the year.

Persons: Tracy Warren, Warren, Astarte, Tammi Jantzen, Katherine Gregory, Gregory, Warren didn't, Nenov, Jantzen, —, we've, we're, Medical's Organizations: Business, Brigham, Women's, Viking Global, Ben Franklin Technology Partners, Children's, Gillette Children's Hospital, Children's Hospital, Arkansas Children's Hospital Locations: Virginia, Minnesota, Arkansas

☆ Startup funding is falling in most major cities. So why is Boston pulling ahead?
▼ + stars: | 2024-02-05 | by ( Melia Russell | Rebecca Torrence | ) www.businessinsider.com time to read: +8 min

AdvertisementThe Bay Area took the lion's share of capital raised on Carta in 2023, followed by Boston, then New York. AdvertisementAccording to Carta data, select metro areas saw the total early-stage funding raised decline by at least a third from 2022 to 2023. Yet early-stage funding was only down 24% in Boston, however, the smallest decrease of the metro areas that Carta tracks. According to Carta data, about $2.6 billion of capital raised in biotech flowed to Boston startups last year. Beyond biotechThe Carta data shows Boston also had strong showings across investment in software-as-a-service and hardware.

Persons: —, Zach Weinberg, Roche, Carta, Founders, that's, Rudina Seseri, Seseri, Peter Walker, Michael Greeley, Greeley, Mark Castleman, Castleman, Clement Cazalot, Cazalot, Walker Organizations: Service, Massachusetts Turnpike, Partners, Business, Carta, Boston, East Coast, Companies, Area, Flare Capital Partners, pharma, Intel Ignite, Glasswing Ventures, Founders, Machinery, Pritzker Group, Armory Square Ventures, Way Ventures, Klaviyo's, New York Stock Exchange Locations: Boston, New York City, East, Boston , Cambridge, Newton , Massachusetts, Newark, Jersey City , New Jersey, New York, San Francisco, Bay, France, Copley

☆ Exclusive: AI healthcare software startup Cohere Health just raised $50 million
▼ + stars: | 2024-02-01 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +4 min

Cohere Health just landed $50 million in Series B extension funding, Business Insider has learned exclusively. Deerfield Management led the Series B extension, with participation from Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners. The Cohere Health team. This year, as it works to get more health plans to use its software, Cohere plans to grow its workforce. In the second quarter of this year, Cohere plans to announce software that will apply AI to medical imaging.

Persons: Siva Namasivayam, Cohere, Axios, Namasivayam, It's, Michael Greeley, Lynne Chou O'Keefe, Greeley, Cohere's Organizations: Cohere, Business, Deerfield Management, Define Ventures, Flare Capital, Longitude, Polaris Partners, Humana, Capital Partners, Cohere Health Locations: Deerfield, Cohere

☆ These are the 7 healthcare startups primed to IPO when the market reopens
▼ + stars: | 2024-01-29 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +2 min

Only one digital health startup went public in the US in 2022 — digital therapeutics company Akili Interactive, whose shares have since crashed a whopping 97%, per MarketWatch. Not a single healthcare startup went public last year. ArriVent Biopharma went public a few days later, bringing in $175 million. AdvertisementIndustry experts remain skeptical about whether the public markets will be ready for a successful healthcare IPO this year. Business Insider has identified seven startups that could be considering an IPO as the markets reopen, based on conversations with top VCs and bankers and public filings.

Persons: —, Metagenomi, ArriVent Biopharma Organizations: Service, Business, Akili Interactive, Alto Neuroscience, Oncology, BrightSpring Health Services, KKR, Walgreens, Industry

☆ This startup is opening a mental health clinic that offers ketamine therapy. We got an exclusive look at the pitch deck it used to raise $5.4 million.
▼ + stars: | 2024-01-25 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +5 min

Read previewVenture investment in mental health startups exploded in 2021. Being Health, an integrated mental healthcare company, is opening its first location, located in Manhattan's Financial District. Services like ketamine infusions and acupuncture will have to be administered in person, but others, like nutrition counseling, will have a virtual option, Sharma said. "When it comes to this novel approach to addressing mental health, you can't do that with telehealth." See the 17-slide pitch deck mental health startup Being Health used to raise $5.4 million in seed funding.

Persons: —, Allie Sharma's, Sharma, Janssen, Haim Dabah, Dabah Organizations: Service, Business, Financial, HDS, FDA, Janssen Pharmaceuticals, Being Health, Services, HDS Capital Locations: New York, New York City

☆ Exclusive: VCs are circling Midi to give more money to the menopause care startup, just 4 months after its last funding round
▼ + stars: | 2024-01-19 | by ( Rebecca Torrence | Melia Russell | ) www.businessinsider.com time to read: +4 min

At the White House, Jill Biden is leading a new initiative to boost federal government research into women's health. Most menopause care startups, including Midi, sell into enterprises to offer the service as a benefit to employees. US companies lose about $1.8 billion each year from workdays missed due to menopause symptoms, according to a Mayo Clinic estimate. While venture funding to women's health startups fell in 2023, according to CB Insights, startups tackling menopause symptoms surged ahead of the pack. Data shows these startups raised $230 million last year, making up a third of all funding to women's health startups.

Persons: hasn't, Semper, Joanna Strober, Sharon Meers, Goldman Sachs, It's, Drew Barrymore, Jennifer Aniston, tailwinds, Michelle Obama, Jill Biden, Biden, workdays Organizations: Business, Midi, GV, Google Ventures, Felicis, Houston, Hermann Health, CBS, McKinsey, White, Mayo Clinic Locations: Midi

☆ Here's why a top VC says healthcare investors should make growth-stage bets right now — and where he's looking for those deals
▼ + stars: | 2024-01-18 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +5 min

As a multi-stage VC fund, Lightspeed has an advantage in its exposure to both early-stage and later-stage healthcare markets, Imanbayev said. And many later-stage healthcare startups still have plenty of room to grow, he said. The first one to three years are often slow-moving for a healthcare startup, too, as it works to get its first partnerships with payers or providers, he said. But they also tend to be less risky, since later-stage startups should have revenue streams or partnerships that demonstrate their value. Lightspeed led value-based care startup Aledade's $260 million Series F in June 2023, an unusually large deal as other investors cut much smaller checks.

Persons: —, Galym, Imanbayev, I'm, There's, Farzad Mostashari, Aledade Tom Sandner, VCs, Abridge, he's, Chris Severn Organizations: Business, Lightspeed Venture Partners, Lightspeed, CVS, Health, Turquoise Health, Pharma, FDA, pharma

☆ These are 30 of the most successful early-stage startup investors in the world, according to a proprietary AI model known as 'Moneyball for VC'
▼ + stars: | 2024-01-17 | by ( Ben Bergman | Samantha Stokes | Rebecca Torrence | ) www.businessinsider.com time to read: +3 min

This story is available exclusively to Business Insider subscribers. TRAC , a San Francisco-based early-stage venture firm cofounded by Fred Campbell, Joseph Aaron, Scott Pyne, Steve Marek, and Dick Fredericks in 2020, has set about to take a more systematic approach to venture capital. Advertisement"A SuperForecaster is in the top 1/10th of 1% of all early-stage investors," Aaron told Business Insider. But now TRAC has agreed to name names, revealing a random sampling of 30 of the 287 SuperForecasters in its model. They rarely make follow-on investments.

Persons: —, Fred Campbell, Joseph Aaron, Scott Pyne, Steve Marek, Dick Fredericks, Phillip Tetlock, Dan Gardner's, Aaron, SuperForecasters Organizations: Service, Business Locations: San Francisco

☆ Some of the best early-stage startup investors share a common trait that should be a lesson for Silicon Valley
▼ + stars: | 2024-01-17 | by ( Dan Defrancesco | ) www.businessinsider.com time to read: +6 min

In today's big story, we're looking at the best investors when it comes to early-stage companies. The big storyPicking winnersCaterina Fake, Cindi Bi, and Suleman AliInvesting can be a crapshoot, especially when it comes to early-stage companies. AdvertisementThe investors, profiled by BI's Ben Bergman, Samantha Stokes, Rebecca Torrence, and Leena Rao, have an incredible track record for early-stage investing. Silicon Valley can be known to have a herd mentality, especially when it comes to venture investors. And yet, some of the best early-stage investors have proven to have far better success going out on their own.

Persons: —, we've, Caterina Fake, Suleman Ali, BI's Ben Bergman, Samantha Stokes, Rebecca Torrence, Leena Rao, Joseph Aaron, cofounders, Tanja Ivanova, isn't, Chanos, Elon Musk, Jim Chanos, Tesla, Musk, Dan Ives, Goldman Sachs, Goldman, Brittany Hosea, Satya Nadella, Sam Altman, Philipp Schindler, Google's, Alyssa Powell, Michelle Obama, Betty White, Steve Harvey, Muhammad Ali, Benjamin Franklin, Al Capone, Calvin Harris, Charles Schwab, They've Organizations: Service, Business, Reuters, Getty, Elon, Tesla, Apple, Microsoft, Google, BI Locations: pant, San Francisco, Brittany, China, Davos, ChatGPT's

☆ Here's an exclusive look at the 16-slide pitch deck that got Bolt cofounder Ryan Breslow to bet on a male birth control startup
▼ + stars: | 2024-01-16 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +4 min

download the appSign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. Read previewThe market for male birth control is growing. AdvertisementThe reversal of Roe v. Wade in 2022 has prompted many people to reevaluate their birth control choices, NEXT CEO L.R. Fox pointed to the increasing rate of vasectomies among younger men and men without children as more evidence that they want to participate in the decision-making process around birth control. Scientists are also working on a hormonal male birth control pill and a topical hormonal gel.

Persons: —, Ryan Breslow's, Roe, Wade, L.R, Fox, I'm, Contraline, Vasalgel Organizations: Service, Business, Sciences, NEXT, Venture, Particular Ventures, Keno, Ventures, Fund, Fox, Sciences isn't, Parsemus Foundation, Food and Drug Administration Locations: Africa

☆ 3 titans will fight to dominate the market for Wegovy in 2024
▼ + stars: | 2023-12-27 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +5 min

Dozens of startups have jumped into the weight-loss market this year as weight-loss drugs, including Wegovy and Ozempic, have exploded in popularity. The few companies with enough money and brand recognition to stand up to Ozempic's distribution challenges — WeightWatchers, Noom, and Ro — can expect to compete for market dominance next year. But WeightWatchers signaled it's going all in on weight-loss drugs by launching its own behavioral program for patients on Ozempic in December. WeightWatchersLike WeightWatchers, Noom has remained staunchly in the weight-loss market since its 2008 launch. Ro launched its own program prescribing weight-loss drugs in January.

Persons: VCs, — WeightWatchers, Sari Kaganoff, WeightWatchers, it's, Sima Sistani, Noom, Ro, Zach Reitano, Kaganoff, Saeju Jeong, Sam Barnes, Aaron DeGagne Organizations: Business, Rock Health, Web, Getty, PitchBook Locations: Ozempic

☆ A $6 billion healthcare-AI startup backed by General Catalyst cut staff after pledging to hire 'aggressively'
▼ + stars: | 2023-12-19 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +3 min

Read previewGeneral Catalyst-backed startups Commure and Athelas merged in October to create a $6 billion healthcare-AI startup. Shortly after the deal closed, though, the newly formed Commure cut staff, according to a leaked email obtained by Business Insider. The layoffs came just a month after Tandon told Business Insider that Commure planned to hire "aggressively" following the merger. Tandon told Business Insider in October that Commure's total headcount following the merger would be about 800. Both Commure and Athelas each had at least five years of cash runway before the merger, Tandon told Business Insider in October.

Persons: —, Tanay Tandon, Tandon, Commure Organizations: Service, Athelas, Business, Bloomberg News

☆ 25 healthcare startups that are set to take off in 2024, according to top VCs
▼ + stars: | 2023-12-18 | by ( Rebecca Torrence | Blake Dodge | ) www.businessinsider.com time to read: +1 min

AetionAetion's website. AetionPicked by: Lynne Chou O'Keefe, the founder and managing partner of Define VenturesWhat the company does: Aetion provides pharmaceutical companies, payers, and regulators with real-world evidence they can use to inform decisions. Aetion provides the real-world evidence that insurers, pharmaceutical companies, and regulatory agencies need to evaluate the value of drugs and inform those conversations, she said. "The cost of specialty drugs, what's happening in the Inflation Reduction Act — all are bellwethers that we need a more value-based-oriented system around therapeutics going forward," she said. — Shelby Livingston

Persons: Aetion, Lynne Chou O'Keefe, O'Keefe, — Shelby Livingston

☆ See the 20-slide pitch deck that got Merck to back an AI-powered biotech creating drugs for untreatable diseases
▼ + stars: | 2023-12-14 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +1 min

Pepper Bio wants to reduce those costs by getting drug developers to the right targets faster, using what it calls a "transomics" approach. Pepper Bio also looks at protein phosphorylation, an indication of how and when proteins are active. Pepper Bio CEO Jon Hu said working with Merck gave the startup insight into the needs of the pharma firms to which Pepper Bio hopes to sell its software. "It allows us to understand, truthfully, what drug developers are struggling with," he said. Here's the 20-slide pitch deck that got Pepper Bio $6.5 million in seed funding.

Persons: Pepper, Pepper Bio's cofounders, Jon Hu Organizations: Business, NFX, Silverton Partners, Mana Ventures, Tensility Ventures, VSC Ventures, Merck, Merck Digital Sciences, pharma

☆ VCs are getting pickier about their weight-loss bets as startups rush to prescribe Ozempic
▼ + stars: | 2023-12-11 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +8 min

Read previewWith the Ozempic craze in full swing, investors are getting picky about the weight-loss startups they want to back. Kaganoff predicted that in the new year some startups prescribing GLP-1s would invest more money in studies using real-world evidence to show their programs work. And despite the Ozempic frenzy, weight-loss startups captured a tiny fraction of the money invested this year. Investors had put about $211 million toward weight-loss startups through mid-November, representing about 3% of digital-health funding over that period, according to PitchBook. Alfie HealthSome unlikely sectors of the healthcare industry stand to benefit from the growth of the weight-loss market.

Persons: —, Sari Kaganoff, Crystal Cox, Kaganoff, Ro, VCs, Michael Greeley, Alyssa Jaffee, 7wireVentures, she's, she'd, Mounjaro, Mercer, Michael Siluk, PitchBook, Alfie Health, it's, Alfie's cofounders, Aaron DeGagne, Jordan, he'd, DeGagne, There's Organizations: Service, Business, Rock Health, Flare Capital Partners, Getty, Employers, Health, Investors, Phenomix Sciences, Mayo Clinic, PitchBook, Tusk Venture Partners, Sword Health Locations: GLP

☆ How Mark Cuban forced the biggest US pharmacy to upend its business
▼ + stars: | 2023-12-05 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +5 min

The new program includes a set markup for medication costs, a step toward drug pricing transparency. The retailer has been facing pressure from new models like Mark Cuban Cost Plus Drugs. They've been especially focused on pharmacy-benefit managers and the lack of transparency around how much drugs cost. How Mark Cuban changed drug pricingCuban's pharmacy buys drugs directly from manufacturers and sells them to consumers at a 15% markup, plus pharmacy fees. AdvertisementBut the announcement looks to be a step in the right direction for drug pricing transparency.

Persons: —, Mark, Prem Shah, Mark Cuban, GoodRx, PBMs, Kroger, it's Organizations: CVS, Cuban, Plus, Service, Mark Cuban, Federal, US Federal Trade Commission, CVS Health, Kroger, Walgreens, Drug, Wall Street Locations: California

☆ Why Hims & Hers won't prescribe Ozempic for now in its new weight-loss program
▼ + stars: | 2023-11-27 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +2 min

When Hims & Hers launches its new weight-loss program, the digital-health company won't be joining in on the Ozempic craze, its CEO, Andrew Dudum, said. While pricey drugs like Ozempic and Wegovy have exploded in popularity this year for their potential to help people lose weight, Hims & Hers plans to offer cheaper generic medications for weight loss, at least initially. Ro's weight-loss program was fueling fast growth for the startup this year, but some patients struggled with insurance denials and delays in communication with Ro. Dudum said during the company's third-quarter earnings call that Hims & Hers expected weight management to be "an extraordinarily valuable category." Next year, in addition to launching its weight-loss program, the company plans to expand its new AI engine, which it's been beta testing in its psychiatry patients.

Persons: Andrew Dudum, Dudum, It's Organizations: Business

☆ Women are turning to Facebook for a DIY approach to getting pregnant
▼ + stars: | 2023-11-14 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +8 min

Some women have turned to Facebook groups to connect with free sperm donors and skirt sperm banks. But after 10 vials of donor sperm, she was out $10,000 and still didn't have a child. Gordy is a serial sperm donor — he says his donations have produced 70 children to date. Kristina GrahamShe's since worked with two free sperm donors at different times, both of whom she met on Facebook. Women may have to weed through some creeps when looking for a sperm donor on Facebook.

Persons: —, Angela, Kyle Gordy, Gordy, Kyle, Crystal Cox, Sean Tipton, Kristina Graham, Kristina Graham She's, She's, she's ovulating, Graham, she'd, Tyree Kelly, he's atoning, Tyree Kelly Tyree Kelly, Kelly, Angela said, who've, Wong Maye, Rebecca Torrence Organizations: Facebook, Service, American Society for Reproductive Medicine, Food and Drug Administration Locations: ejaculate, Arizona, Maine, Tipton, rtorrence@insider.com

☆ Once loyal Calibrate patients say they regained weight after the startup struggled to get them weight-loss meds on time
▼ + stars: | 2023-11-02 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +14 min

Christina started taking Wegovy in September 2021 after getting a prescription through Calibrate, a startup that promises science-backed help with weight loss. She never received medication through Calibrate again, and she's since gained back all the weight she lost. Calibrate says its goal for Masters patients is to get them off weight-loss medications and help them maintain the weight loss they achieved. A former employee on Calibrate's clinical team said the startup allocated fewer doctors to second-year patients because those patients historically required less help from Calibrate. At least four second-year patients Insider spoke with said they sought refunds from Calibrate after they didn't receive the services they paid for.

Persons: Christina, She'd, I'm, Florian Gaertner, they've, They've, Isabelle Kenyon, Kenyon, Fortune, Jenny Craig, Ozempic, it's, Katie, Calibrate's, didn't, It's, James, they'd, Arantza Pena Popo, Disha, aren't, hasn't, Michael Siluk, Beth Organizations: Getty, Calibrate's, Better, LinkedIn Locations: York, Chicago

☆ Exclusive: How Calibrate stumbled from hot weight-loss startup to $20 million sale under threat of bankruptcy
▼ + stars: | 2023-11-02 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +6 min

Facing the threat of bankruptcy, weight-loss startup Calibrate was forced to make a tough deal with private equity firm Madryn Asset Management, according to company documents reviewed by Insider. Under the terms of the deal, Madryn took a 70% stake in Calibrate in exchange for just $20 million, the documents show. Calibrate, Madryn, Kenyon, and the company's VC backers didn't immediately return messages seeking comment for this story. Some longtime patients have regained much of the weight they lost after Calibrate failed to get them medications, Insider reported on Thursday. Under the deal, Madryn exchanged $20 million of its loans for senior equity in Calibrate.

Persons: Madryn, Isabelle Kenyon, She's, Kenyon, didn't, Fortune, Michael Siluk, They're Organizations: Asset, Tiger Global, Founders Fund, Optum Ventures, Madryn, Tiger, Getty, Owners, LinkedIn Locations: Madryn

☆ Exclusive: Weight-loss startup Calibrate is selling itself to a private equity firm as patient complaints mount
▼ + stars: | 2023-10-20 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +1 min

Calibrate is selling itself to one of its investors, private equity firm Madryn Asset Management. The weight-loss startup is also planning to restructure, per two people with knowledge. The sale comes as Calibrate faces customer complaints and struggles to get some patients medications. Weight-loss startup Calibrate is selling itself to the private equity firm Madryn Asset Management, Insider has learned. The sale was announced in a Slack message to the startup's staff on Friday, according to two employees with direct knowledge.

Persons: couldn't Organizations: Asset Management

☆ Healthcare-staffing startup Nomad Health just slashed its workforce for the second time this year
▼ + stars: | 2023-10-20 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +2 min

Healthcare staffing firm Nomad Health just cut its workforce for the second time this year, as high inflation continues to squeeze hospital budgets. Nomad Health, which connects nurses and other health professionals to open jobs, confirmed in an email to Insider that it announced a round of layoffs affecting its nonclinical workforce on October 3. Alexi Nazem Alexi NazemNomad Health cited similar factors when it slashed 17% of its workforce, or 119 employees, in February. Nomad Health also banked extra cash last year, raising $105 million in June 2022 at an undisclosed valuation. Do you work at Nomad Health?

Persons: Maquel Shaw, Alexi Nazem Alexi, Alexi Nazem, Forbes, he'd, Rebecca Torrence Organizations: Nomad, Nomad Health Locations: rtorrence@insider.com

☆ Hinge Health is shooting for profitability in 2024 as the physical-therapy startup prepares for an IPO
▼ + stars: | 2023-10-16 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +1 min

Hinge Health is preparing for an initial public offering once market conditions become favorable. CEO Daniel Perez said Hinge Health projects it will hit a cash flow break-even in 2024. The digital musculoskeletal therapy startup is now looking for smaller companies to acquire. After Hinge Health raised $300 million in Series D funding in January 2021, CEO Daniel Perez told Reuters that the startup hoped to go public in 2022. That was before interest rates soared and the economy slumped and closed the IPO window for healthcare startups that planned to make their public-market debuts.

Persons: Daniel Perez, Perez Organizations: Reuters Locations: Las Vegas

☆ 2 General Catalyst health-data startups are joining forces to create a $6 billion AI colossus and lay the groundwork for an IPO
▼ + stars: | 2023-10-09 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +4 min

The General Catalyst-backed startups Commure and Athelas are merging in a deal to bring more artificial-intelligence tech to hospitals and health systems. The new company, which is keeping the name Commure, plans to stack Athelas' software on top of Commure's data platform for health systems. General Catalyst is investing $70 million in the new firm at a $6 billion valuation, and Tanay Tandon, the founder and CEO of Athelas, will lead the combined company. Commure will consider companies making those tools in a range of categories, including credentialing, contracting, and patient engagement, he said. The company has about 100 open positions, Tandon said, and expects to hire hundreds more people in 2024.

Persons: Tanay Tandon, Hemant Taneja, Tandon, Commure, Catalyst, Athelas Organizations: Catalyst, General

☆ See the 10-slide presentation a startup used to land $8 million from General Catalyst to speed up rare-disease research with AI
▼ + stars: | 2023-09-20 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +1 min

Medeloop just raised $8 million in seed funding led by General Catalyst. The startup uses AI to help speed up research tasks such as grant applications and data collection. It's working with researchers at universities in California and Canada. Caissie, who was born in Canada and previously worked as an oral and facial surgeon, wanted to build tech to solve problems he'd faced as a doctor and researcher. In 2021, he left Montreal to attend Stanford University's business school to get his MBA and build a tech platform, now known as Medeloop, that would help him conduct research quicker.

Persons: Medeloop, General Catalyst, Rene Caissie, Caissie, he'd Organizations: General, Stanford Locations: California, Canada, Montreal

Search resuls for: "Rebecca Torrence"

25 mentions found